Wintergreen Acquisition Corp. operates as a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Beijing, Beijing. The company went IPO on 2025-05-29. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. The firm intends to focus on the technology, media, and telecommunications (TMT) industries. The firm has no operations and not generated revenues.
Wintergreen Acquisition Corp の最大収益セグメントは Bulk Medicine で、最新の利益発表における収益は 6,909,415,147 です。地域別に見ると、China, including Hong Kong が Wintergreen Acquisition Corp の主要市場であり、収益は 12,051,782,799 です。